Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Shares of Eden Research plc (LON:EDEN) fell 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The company’s 50 day moving average price is GBX 3.88 and its 200 day moving average price is GBX 3.95.

Insider Transactions at Eden Research

In related news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction that occurred on Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Company insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.